Cargando…

An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo

The classical manifestation of COVID-19 is pulmonary infection. After host cell entry via human angiotensin–converting enzyme II (hACE2), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can infect pulmonary epithelial cells, especially the AT2 (alveolar type II) cells that are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kuo, Tang, Muxue, Xu, Wei, Meng, Xinfeng, Jin, Hengwei, Han, Maoying, Pu, Jing, Li, Yutang, Jiao, Fanke, Sun, Ruilin, Shen, Ruling, Lui, Kathy O., Lu, Lu, Zhou, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288645/ https://www.ncbi.nlm.nih.gov/pubmed/37307455 http://dx.doi.org/10.1073/pnas.2207210120

Ejemplares similares

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
por: Zhou, Xiaoyang, et al.
Publicado: (2023)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice
por: Muturi, Elishiba, et al.
Publicado: (2022)

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
por: DeDiego, Marta L., et al.
Publicado: (2008)

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2022)

COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice
por: Zheng, Jian, et al.
Publicado: (2020)

The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)

Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
por: Vidal, Enric, et al.
Publicado: (2021)

Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
por: Shang, Chao, et al.
Publicado: (2021)

Highly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice
por: Asaka, Masamitsu N., et al.
Publicado: (2021)

Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2023)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function
por: Winkler, Emma S., et al.
Publicado: (2020)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues
por: Shang, Chao, et al.
Publicado: (2021)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice
por: Amruta, Narayanappa, et al.
Publicado: (2021)

Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice
por: Kim, Byeongseok, et al.
Publicado: (2023)

Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2
por: Ulbegi Polat, Hivda, et al.
Publicado: (2023)

Sex-Specific Differences in the Pathogenesis, Endothelial Dysfunction, and Hypercoagulability of Sars-Cov-2 Infection in K18-hACE2 Mice
por: Aiolfi, Roberto, et al.
Publicado: (2022)

Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models
por: Jeong, Haengdueng, et al.
Publicado: (2022)

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
por: Cáceres, C. Joaquín, et al.
Publicado: (2021)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice
por: Jiang, Xiaoliang, et al.
Publicado: (2022)

Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
por: da Silva Santos, Yasmin, et al.
Publicado: (2023)

Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice
por: Olivier, Paul, et al.
Publicado: (2023)

BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19
por: Ji, Rui-Ru, et al.
Publicado: (2021)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Rodriguez, Jorge H.
Publicado: (2021)

Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model
por: Seibert, Brittany, et al.
Publicado: (2021)

Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice
por: Olivarria, Gema M., et al.
Publicado: (2021)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants
por: Gilliland, Theron, et al.
Publicado: (2023)

Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction
por: Wang, Chaojie, et al.
Publicado: (2023)

A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
por: Huang, Qingrui, et al.
Publicado: (2021)

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
por: Wong, Ting Y., et al.
Publicado: (2022)

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
por: Seehusen, Frauke, et al.
Publicado: (2022)

Prediction of infectivity of SARS-CoV-2 virus based on Spike-hACE-2 interaction
por: Chaudhuri, Dwaipayan, et al.
Publicado: (2022)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
por: Aw, Zhen Qin, et al.
Publicado: (2022)

One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
por: Liu, Ruikang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7o2d040p2srd61cg7rf9lki0i4